Monday, August 14, 2017 5:30:04 PM
I just received a call from PSEC (I had left a message on Barry's voice mail). Naturally, no comment on whether they are on course towards the analysts' earnings consensus (.20), but no explanation about possible causes of the price drop either. The letter seems available in paper mail format only, it seems generated by a good office printer. And they do send it out quarterly, I simply hadn't received it till now. The most worrisome statement I found in it is "Our twelve month return for the fiscal year just ended will not easily be repeated in any year." (verbatim). As I remarked to my caller, this is not the kind of message to send out about any company, but especially one that is under pressure for any reason, whether or not expectations are going to be met. With mere weeks to go to the next ER, I got worried; but I am sure others panicked, that is the only explanation I am left with, since the caller didn't provide others. All the worse case scenarios described in the posts following mine seem feasible, I am hoping the one about price drop is grossly pessimistic, and I am staying put hoping for recovery: my entry point is closer to the 52 weeks high, so if I sold now, it would be a matter of just what kind of loss I would incur. Since the fundamentals seem in order, I am biting the bullet (and swelling my liver). Unfortunately, somebody's observation that similar stocks have been affected by market conditions and imponderables, seems optimistic: a similar stock I have been watching, BRG, is up more than 3% today, for no apparent specific reason, while PSEC toed the NASDAQ.
Concerning insiders’ sell offs (though the letter states “We are committed to the long term and never sold a single share”), which I suspected immediately, I am re-thinking the quandary: they are public information that must be filed with the SEC; even options (which in my message I remarked they must be putting) are not made out of thin air, the shares must come from somewhere. If they were insiders’, form 4’s would have to be filed (though I am sure there are workarounds) within 48 hours of transactions.
Recent PSEC News
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/11/2024 08:33:01 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/11/2024 08:31:26 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 03/07/2024 09:10:18 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/04/2024 10:23:42 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/04/2024 09:04:36 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/01/2024 09:16:30 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/29/2024 09:10:44 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/26/2024 09:06:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:01:45 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/23/2024 09:57:10 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/20/2024 09:02:38 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/20/2024 09:01:52 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/12/2024 09:50:54 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/08/2024 10:21:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:20:13 PM
- Prospect Capital Announces December 2023 Financial Results and Declares 80th Consecutive $0.06 Dividend • GlobeNewswire Inc. • 02/08/2024 09:44:54 PM
- Prospect Capital Schedules Second Fiscal Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 02/06/2024 09:01:25 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/05/2024 09:03:43 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/01/2024 09:03:56 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 01/29/2024 09:03:57 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 01/29/2024 09:02:57 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 01/25/2024 09:02:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:01:18 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 01/22/2024 09:11:48 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 01/22/2024 09:09:49 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM